Executive Order On The List Of Occupational Diseases Notified From 1. January 2005

Original Language Title: Bekendtgørelse om fortegnelse over erhvervssygdomme anmeldt fra 1. januar 2005

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
Overview (table of contents)



Annex 1



List of occupational diseases notified from 1. January 2005





Annex 2



Index



The full text of the Decree on the list of occupational diseases notified from 1. January 2005

Under section 7 (1) (8). 1 of the law on workers ' compensation, in accordance with article 3. lovbekendtgørelse nr. 278 of 14. March 2013 and § 7 (1) (8). 1 of law No. 1528 by 21. December 2010 on workers ' compensation in Greenland and negotiated with occupational disease Committee, shall be set: § 1. A disease may be recognised as an occupational disease, see. § 7 (1) (8). 1 if the following conditions are met: 1 General) The harmful effects must have a strength and temporal extent, as after medical documentation may cause the disease.

2) disease after medical evidence consistent with the harmful effects and disease.

3) Disease may not with overwhelming probability is due to factors other than the professional regulation. § 8, paragraph 1.

(2). In addition, specific conditions are mentioned under each item in the list, see. Annex 1, must be met, see possibly cue register in annex 2.

§ 2. The notice shall enter into force on the 1. November 2013 and shall from that date apply in determining whether a disease is reported from 1. January 2005, can be recognised as an occupational disease, including when the proceedings are resumed after § 41. For Greenland shall notice apply in determining whether a disease is reported from 1. January 2011, may be recognised as an occupational disease, including when the case is resumed under section 46 of the law on workers ' compensation in Greenland.

(2). At the same time repealed Executive Order No. 829 by 27. June 2013 on the list of occupational diseases notified from 1. January 2005.

(3). This notice shall also apply to decisions taken by injuries before the entry into force of the Executive order, and which has been brought before the Appeals Board. It does not however apply if notice sharpens the previous conditions for recognition.

Injuries, the 24. October 2013 Anne-Marie v. Rasmussen/Jane Hansen



Annex 1 list of occupational diseases notified from 1. januar 2005











Punkt









Disease









Impact







 







Group A: Main









A.1.





Noise-related hearing impairment (DLA professionalis) loud noise for several years







A.2.





Cataracts





Beam energy







A. 3.1.





Sugar and melk aries, in particular on the amount of forflader (facialflader) at least 5 years of tooth-damaging exposure in sugar-and melbranchen within 7 years







A. 3.2.





Tooth wear of the third or fourth level of several teeth in the permanent dentition, on teeth chewing surfaces and/or fortændernes cutting edge (abrasion) at least 5 years of tooth-friendly production work with abrasive in the air within 7 years





 





Other diseases of the head and brain: Group I, J and K eye disease: see also E. 5.2.



 



 







Group B: back, neck-shoulder and hip









B. 1.





Chronic lænderygsygdom with pain (lumbago-sciatica, lumbar herniated disc, degenerative lænderygsygdom) a. Rygbelastende lifting with lift/pull up of heavy objects and a total daily lifting load of many tons in a longer number of years

b. Rygbelastende lifting work with common, extremely heavy and awkward single lift and a total daily lifting load of several tons of a longer number of years

c. Rygbelastende care work with many day to day handling of adults or more disabled children in a number of years

d. Rygbelastende, daily exposure to whole-body vibration from the heavily vibrating vehicles for an extended number of years







(B). 2.





Chronic neck-shoulder-pain (cervikobrakialt syndrome) Fast repetitive movements in shoulder/upper arm, possibly in combination with neck bending and/or static load of neck-shoulder girdle, in a number of years.







B. 3.





Osteoarthritis in both hip joint (periarticular coxae primaria bilateralis) Hip invasive lifting work with many heavy single lift and a total daily lifting load of several tons in a long number of years





 







Group c: Arm and shoulder









C. 1.





Tenosynovitis (tendovaginitis) and inflammatory-like changes in late or in tissue surrounding the tendon (tendinitis and peritendinitis) powerful and repetitive (repeated) labour movements, in combination with an assessment of the hand's working position during load







(C). 2.





Carpal tunnel syndrome





a. Work with strongly vibrating hand tools for a longer time (hand-arm vibration)

b. A combination of rapidly repeated, powerful and/or awkward, wrist-friendly labour movements for long periods of time

c. Work with objects, resulting in a direct and continuous pressure on the median nerve in karpaltunnellen for longer

d. as a complication of tenosynovitis on wrist bend page, which may be recognised in accordance with the occupational disease list







C.3.1.





White finger (Raynaud's syndrome, morbus Raynaud) Work with strongly vibrating hand tools (hand-arm vibration)







(C). 3.2.





Peripheral neuropathy in hand/fingers (morbus alius nervorum periphericorum) c. 3.3.





Osteoarthritis of the elbow or wrist (periarticular primaria/other specified forms of arthrose) (carpal tunnel syndrome: c. 2) c. 4.1.





Tennis elbow (epicondylitis lateralis) a. powerful and repetitive (repeated)







(C). 4.2.





Golf elbow (epicondylitis medialis) labour movements

b. powerful labour movements in awkward positions

c. powerful static work







C. 5.1.





Rotator cuff syndrome/impingementsyndrom





a. Repetitive (repeated) and
C. 5.2.





Symptoms from or change in the long biceps tendon (tendinitis, caput longum bicepstendinit musculus bicipitis brachii)





powerful shoulder movements, in combination with an assessment of the situation at the load arm

b. Static lift of the upper arm to about 60 degrees or more





 





Other disorders of the arm: Group in





 



 







Group D: Ben









(D). 1.





Osteoarthritis of the knee joint (periarticular genus) Knæliggende and/or squatting work in many years







D. 2.





Inflammatory-like changes in a Bursa in the knee (bursitis) (Bursitis elsewhere: j. 1) sustained, exogenous pressure for days or for a longer period of time







D. 3.





Disease in the knee joint meniscus (meniscus laesio genus) Work in the squatting position under cramped conditions for days or for a longer period of time







D. 4.





Patellar tendinitis (jumpers knee, tendinitis/tendinosis patellaris) Jumping/running with frequent start sentences and braking (acceleration/deceleration) under bending and stretching of the knee





 







Group E: Lungs and Airways









E. 1.





Silicosis





Kiselsyreanhydrid



(for example, by sandblasting, iron casting and stone carving)









E. 2.





Lung fibrosis





Other Silicon compounds







E.3.1.





Pulmonary asbestosis





Asbestos (for example, by working with E. 3.2.





Widespread connective tissue formation in the pleura with influenced lung function







insulation materials of asbestos, asbestos-cement (eternit), brake linings)









E. 3.3.





Pleural plaques without pulmonary asbestosis



 





E. 4.





Dust lungs (pneumoconiosis) Dust or fumes from aluminium or its compounds or dust from hard metals







E. 5.1.





Allergic inflammation of the nasal Mucosa (rhinitis allergica) Dust or fumes from:

a. Plants or plant products







E. 5.2.





Allergic, inflammatory-like changes in the eye's mucous membranes (conjunktivitis allergica) Animals or animal products

b. Enzymes, dyes, persulfate salts, artificial resin or drugs and precursors of these

c. Isocyanates and anhydrides in certain

epoxy resins







E. 6.





Lung disease after organic matter (allergic alveolitis, luftfugtersyge and byssinosis; "farmer's lung", "mushroom worker's lung ' and ' ´ bird breeder's lung ' ´)







Organic materials (for example, fungal spores, animalistic protein etc.)







E. 7.





Chronic bronchitis/COPD





Vapours/gases/dust and/or smoke for many years







E. 8.





Asthma (allergic and non-allergic) Dust or fumes from:

a. Plants or plant products

b. Animals or animal products

c. Enzymes, dyes, persulfate salts, artificial resin or drugs and precursors of these

d. Isocyanates and anhydrides in certain

epoxy resins

e. Chrome and some of its compounds

f. Cobalt

g. Aluminum

h. carbide

in Nickel.







E. 9.





Lung disease with impaired lung function of obstructive type





Isocyanates







E. 10.





Lung inflammation





Vanadium and its compounds





 





Other diseases of the lungs, respiratory tract and organs: Group I, J and K





 



 







Group F: mental illness









F. 1.





Post traumatic stress disorder

(when symptoms of the disease occur at the latest within 6 months, and the disease is fully present within a few years)





Traumatic events or situations of shorter or longer duration of an exceptionally threatening or kata strofeagtig nature





 







Group G: Skin









G. 1.





Allergic dermatitis (Eczema after chrome: in 5.1, Nickel eczema: i. 9) Allergens (for example, no preservatives, additives, latex rubber, food etc.)







G. 2.





Other irritating skin conditions (for example, toxic dermatitis) one or more irritant substances or physical factors





 





Other skin conditions: Group I and K





 



 







Group h: Infectious and parasitic diseases









H. 1.
Infectious and parasitic diseases from animals or animal material (for example, tetanus, psittacosis, Q-fever, undulant fever, anthrax, Weil's disease, tuberkuløs infection from animals) Animals, animal material or other relevant source of infection (for example at work in refuse disposal installations and wiring) h. 2.





Infectious diseases from humans (for example, hepatitis, staphylococci, tuberculosis, AIDS) Blood, tissue, tissue fluids or other biological material from people with the same type of infection







(H). 3.





Tropical diseases (such as malaria, trypanosomiasis, dengue fever, amøbiasis, pappatacifeber, malta fever, fall-back fever, yellow fever, plague, leishmaniasis, framboesi, lepra, typhus and other febrile diseases induced by richettsia) transfer of disease (infection)





 







Group i: Diseases after chemical substances









In 1.1.





Nerve inflammation





Arsenic and some of its compounds (for example, in the chemical and metallurgical in 1.2





Cirrhosis of the liver







industry, in the pharmaceutical industry and in the manufacture of acids and wood preserving agents)









I.2.





Beryllium lung





Beryllium and certain of its compounds (for example, in porcelain and ceramics industry and electronic and nuclear (nuclear) industry) carbon monoxide, phosgene, hydrogen cyanide, cyanide salt, cyanide compounds and cyanates (3):







I.3.1.





Toxic brain damage/dementia (severe carbon monoxide poisoning with loss of consciousness, toxic encephalopathy) carbon monoxide







I. 3.2.





Liver inflammation



(hepatitis toxica)







Acrylonitrile







I.4.





Kidney injury



(cadmium poisoning)







Cadmium and some of its compounds (for example, in electroplating and color industries) in 5.1.





Allergic eczema





Chrome and some of its compounds







In 5.2.





Inflammation of the mucous membranes of the eyes and upper respiratory tract







(for example, in metal and color industry,









I. 5.3.





Perforation of the nasal partition screens







by cement casting and by the use of chrome tanned products)









In 6.1.





Toxic brain damage/dementia (toxic encephalopathy) Mercury and some of its compounds (for example in electrochemical and i. 6.2.





Kidney damage (nephrotic syndrome) electromechanical industry, by laboratory work and the manufacture of measuring instruments)









I.7.





Manganese (manganese induced Parkinsonism) Manganese and some of its compounds after severe exposure (for example in the manufacture of tørelementer as well as colours and varnishes). 8.





Lung damage





a. nitric acid, nitrogen oxide or ammonia and its connections after severe exposure (for example in the manufacture of fertilizers, explosives, inks and varnishes in metal etching, gelbbrænding, nitric acid is applied, the incineration of nitrogenous products (fertilizer) and in refrigeration) b. sulphur dioxide or sulphuric acid after severe exposure (for example in the manufacture of sulphuric acid and in paper-, battery-, SOAP-and kunstsilke industry)

c. Chlorine, bromine and iodine and their inorganic compounds, as well as fluorine and its compounds, after severe exposure (for example, as bleaching agents in the industry). 9.





Allergic eczema





Nickel







I. 10.





Hard metal lung





Cobalt (for example in the manufacture of special steels, coins and jewelry) i. 11.1.





Polyneuropathy





Phosphorus and some of its compounds







I. 11.2.





Pulmonary edema with lung injury







(for example, in the manufacture of pesticides)









I. 12.1.





Toxic brain damage/dementia (toxic encephalopathy) lead (for example in battery-, color-and plastics industry) in. 12.2.





Nerve inflammation (peripheral polyneuropathy). 12.3.





Kidney damage (chronic interstitial nephritis). 13.





Toxic brain damage/dementia (toxic encephalopathy) hydrogen sulphide after severe exposure







I. 14.





Tallium poisoning (hair loss, nerve inflammation and visual disturbances) Tallium and its connections (for example in the manufacture of fireworks and rat poison) in 15.





Fluorosis (bone disease) fluorine and its compounds after severe exposure





 

 
Hydrocarbons and their derivatives (i. 16): (for example chemical products containing organic solvents (colours, lacquers, cleaning agents, raw materials from the chemical industry and the plastics industry, etc.)







I. 16.1.





Toxic brain damage/dementia (toxic encephalopathy) organic solvents







I. 16.2.





Kidney damage (glomerulonephritis) i. 16.3.





Liver inflammation (hepatitis toxica) Klorede solvents







I. 16.4.





Anaemia (aplastic anemia) Benzene







I. 16.5.





Nerve inflammation (peripheral polyneuropathy) Hexane and metylbutylketon





 

 





Organic forms of nitrogen (nitrogen):









I. 17.





Liver inflammation (hepatitis toxica) Dimetylformamid



(for example, chemical products containing amines, nitroaminer, etc., within the food, dye and explosives industry etc.)





 





Other diseases after chemical substances: Group (E), (G) and (K)





 



 







Group j: Other diseases









J. 1.





Inflammatory-like changes in a Bursa, places other than knee (bursitis) (Bursitis in the knee: d. 2) sustained, exogenous pressure for days or for a longer period of time







J. 2.





Nerve paralysis





External pressure







J. 3.





Diseases caused by work in compressed air





Work in compressed air





 







Group K: Cancers

1)











Blood-and lymph-forming organs:









K. 1.1.





Leukemia







Substances:



a. Benzene

(b). Ethylene oxide

(c) 1.3-butadiene.



Processes:



d. Rubber Industry

e. Oil refining

f. Boot and shoemaking and repair







K. 1.2.





Myelogenous leukemia





a. Ionising Radiation (such as x-ray and gamma radiation)

b. formaldehyde







K. 1.3.





Lymphatic and blood-forming organs





1.3-Butadiene







K. 1.4.





Non-Hodgkin Lymphoma





a. 2, 3, 7, 8-Tetraklorodibenzo-para-dioxin (dioxin)

b. Tetrakloretylen

c. Trikloretylen









Digestive organs:









K. 2.1.





Peritoneum (mesothelioma) a. Asbestos

b. Erionit

c. Talc containing asbestos-like fibers







K. 2.2.





Liver and bile ducts





a. Aflatoxins

b. Trikloretylen







K. 2.3.





Liver





a. Hepatitis B virus

b. Hepatitis C virus

c. Vinyl chloride







K. 2.4.





Liver (angiosarkom) Vinyl chloride







K. 2.5.





Stomach





Inorganic lead compounds







K. 2.6.





Nasal pharynx





Formaldehyde









Skin:









K. 3.





Skin







Substances:



(a). Arsenic and its compounds

b. Antracen

c. Creosote connections

d. mineral oil, untreated and easily treated

e. Råparaffin

such Shale oil or lubricants extracted from shale

g. solar radiation

h. Sod

coal-tar and coal tar pitch in.



Processes:



j. coke production

k. coal gasification

l. Oil refining









Respiratory tract:









K. 4.1.





Lung







Substances:







 

 



a. 2, 3, 7, 8-Tetraklorodibenzo-para-dioxin (dioxin)

b. Alpha-chlorinated toluener and benzoylklorid (combined)

(c). Arsenic and its compounds

d. Asbestos

e. Beryllium and its compounds

(f) Bis (chloromethyl). methyl ether and cloromethylether (technical degree) (oat cell)

g. Cadmium and its compounds

h. insecticidal (non-

containing arsenic are being)

i. Chromium Compounds

j. Crystalline quartz

k. Nickel compounds, including combinations of nickel oxides and sulphides of nickel refining industry
l. Particles of metallic cobalt containing tungsten carbide (tungsten)

m. passive smoking

n. Radon and "radon daughters"

o. mustard gas (sulphur mustard)

p. Sod

coal-tar and coal-tar pitch q.

Strong inorganic acid mists containing r. sulphuric acid

s. Talc containing asbestos-like fibers

t. exhaust fumes from diesel engines

u. Bitumen by asphalt-roof work



Processes:



v. Aluminum manufacture

w. iron and metal casting

x. coke production

y. coal gasification

z. painter (occupational exposure as)

æ. Mining of iron ore (iron shine) with radon exposure

ø. Production of art glass, glass containers and pottery







K. 4.2.





Pleural (mesothelioma) a. Asbestos

b. Erionit

c. Talc containing asbestos-like fibers







K. 4.3.





Nasal cavity and sinuses







Substances:







 

 



a. formaldehyde

b. Chromium Compounds

c. Nickel compounds, including combinations of nickel oxides and sulphides of nickel refining industry

d. wood dust



Processes:



e. manufacture of isopropyl alcohol by strong acid process

f. furniture and Cabinet manufacturing

g. Boot and shoemaking and repair







K. 4.4.





Mucous membranes in the sinuses and processus masteoideus (epiteliale tumours) Radium-226







K. 4.5





Voice box







Substances:







 

 



a. Asbestos

b. mustard gas (sulphur mustard)

Strong inorganic acid mists containing c. sulphuric acid



Processes:



d. Isopropyl alcohol, manufacture by strong acid process









Urinary tract:









K. 5.1.





Kidney





Coke production







K. 5.2.





Urinary bladder







Substances:



a. 2-Napthylamin

b. 4-Amino piezoelectric

c. 4-chloro-ortho-toluidine and its strong (hydrochloride) salts

d. 4-4 '-chloro aniline metylbis (MOCA)

(e). Arsenic and its compounds

such as Benzidine and benzidinbaserede dyes

g. Ortho-toluidine

Coal tar and coal tar pitch h.

in exhaust gas from diesel engines.



Processes:



j. Aluminum manufacture

k. Auraminfremstilling

l. Barber work in men

m. coal gasification

n. Rubber Industry

o. painter (occupational exposure as)

p. Magenta production (fuchsin)

q. Boot and shoemaking and repair





 







Other bodies or cancers:









K. 6.1.





Connective tissue





2, 3, 7, 8-Tetraklorodibenzo-para-dioxin (dioxin) k. 6.2.





Breast





Ionizing radiation (such as x-ray and gamma radiation)







K. 6.3.





Bone (Sarcoma), Radium-226 and Radium-228







K. 6.4.





Cancer without specification (all cancers, which are not included under other items) 2, 3, 7, 8-Tetraklorodibenzo-para-dioxin (dioxin) k. 6.5.





Thyroid gland





Ionizing radiation (such as x-ray and gamma radiation)





 







Group L: Birth Defects







 





Fetal disease/injury









Documented infection/influence in the mother during pregnancy







 





Following infections:





 





L. 1.1.





Congenital cytomegalovirusinfektion





Cytomegalovirus







L. 1.2.





Neonatal hepatitis B virus infection resulting in chronic bearer mode





Hepatitis B virus







L. 1.3.





Neonatal herpes





Herpes simplex virus







L. 1.4.





Congenital or neonatal HIV-infection





Human immunodeficiency virus (HIV)







L. 1.5.





Brain inflammation





Listeria







L. 1.6.





Congenital infection





Parvovirus B-19







L. 1.7.





Congenital rubellasyndrom





Congenital rubellasyndrom (rubella virus)







L. 1.8.





Microcephali, hydrocephalus, retinal inflammation, inflammation of the liver





Toxoplasmosis (rabbit sick)







L. 1.9.
Varicellasyndrom congenital or neonatal varicella





Varicella zoster virus (chickenpox virus)





 





Following chemical substances:





 





L. 2.1.





Microcephali, mental retardation





Methylmercury







L. 2.2.





Encephalitis, retarded development





Lead





 





Following other adverse effects:





 





L. 3.1.





Microcephali, malignant diseases





Radiation (radioactivity)







L. 3.2.





Premature birth and complications in addition





Extreme physical work load





 





Following physical trauma:





 





L. 4.





Premature birth and complications in addition





Accidents and violence





 

 





1)





Contents of Group K is based on IARC's monograph series ´ (IARC Monographs on the Evaluation of Carcinogenic Risks two Humans), vols. 1-88, volume 100F and upcoming volume 103. The who International Agency for Research on Cancer, Lyon.













Annex 2 index

Cue the register includes diseases, influences and concepts, which are mentioned in annex 1 of the basic regulation. section 1 of the Executive order.

Although the disease and/or impact is mentioned in the inventory, it does not necessarily imply that the disease and/or impact is subject to the same list. There should be pointed out that both the General conditions as set out in section 1 of the plan, and the special conditions mentioned in the individual points must be complied with, see. section 1, paragraph 2.







 

 



 

 







Illness/impact/concept:









Group/item:









1.3-Butadiene





K. 1.1. c, k. 1.3







2-Naphthylamine





K. 5.2. (a)







2, 3, 7, 8-Tetrachlorodibenzo-para-dioxin (dioxin)





1.4. a, k. k. 4.1. a, k., k. 6.1 6.4







4-Amino piezoelectric





K. 5.2. (b)







4-chloro-ortho-toluidine and its strong (hydrochloride) salts





K. 5.2. (c)







4, 4 '-Methylbiskloranilin (MOCA)





K. 5.2. (d)





 

 







(A):





 





Abrasion (dental wear)





A. 3.2







Acceleration/deceleration (ProcessStartInfo phrases/braking)





D. 4







Acrylonitrile





I. 3.2.







Aflatoxins





K. 2.2. (a)







AIDS/HIV





H. 2, l. 1.4







Battery-industry





I. 12, 13 in.







Elbow (tennis elbow, golf elbow)





C. c. 4.1, 4.2







Alpha-chlorinated toluener and benzoylklorid (combined)





K. 4.1. b







Allergic inflammation of the nasal membranes (rhinitis allergica)





E. 5.1







Allergic inflammation similar changes in the eye's mucous membranes (conjunktivitis allergica)





E. 5.2







Allergic eczema





G. 1 in 5.1, i. 9.







Allergic alveolitis





E. 6







Allergic asthma





E. 8







Aluminum





E. 4, E. 8 K. 4.1. v, k. 5.2. (j)







Aluminum production





E. 4, E. 8 K. 4.1. v, k. 5.2. (j)







Amino piezoelectric





K. 5.2. (b)







Amines, nitroaminer





I. 17







Ammonia





I. 8. (A)







Amøbiasis





H. 3







Angiosarkom (primary liver cancer)





K. 2.4







Anhydrides





E. 5, e. 8







Antracen





K. 3. b







Aplastic anemia





I. 16.4







Arsenic





In 1.1, 1.2, K. 3.1. a, k. 4.1. c, k. 5.2. (e)







Periarticular coxae primaria bilateralis (osteoarthritis in both hip joints)





B. 3







Periarticular, genus (osteoarthritis of the knee)





D. 1







Asbestos, asbestsyg disease





E.3.1. E., 3.2, 3.3, k. e. 2.1. a, k. 4.1. d, k. 4.2(a), k. 4.5. (a)







Asbestos-like fibres, talc with





K. 2.1. c, K. 4.2. (c)
Asbestosis





E. 3.1







Asphalt-roof (bitumen)





K. 4.1. u







Asthma, bronchial asthma





E. 8







Atom (nuclear) industry





I. 2







Auraminfremstilling





K. 5.2 k





 

 







(B):





 





Pitch (coal tar pitch)





K. 3.1. in, K. 4.1. q, k. 5.2. h







Benzene





I. 16.4, k. 1.1. (a)







Benzidine and benzidinbaserede dyes





K. 5.2. f







Benzoylklorid





K. 4.1. b







Beryllium, beryllium lung





In 2 K. 4.1. e







Inflammation of the mucous membranes of the eyes and upper respiratory tract





I. 5.3







Inflammatory-like changes in a Bursa (bursitis)





D. 2, j. 1







Biceps tendon, changes in (bicepstendinit)





C. 5.2







Sinus cancer





K. k. 4.3, 4.4







Connective tissue cancer





K. 6.1







» Bird Breeder's lung '





E. 6







Bis (cloromethyl) ether, methyl cloromethyl ether





K. 4.1. (f)







Bitumen in asphalt-roof work





K. 4.1. u







Blood, tissue, tissue fluids and other biological material from people





H. 2







Blood and lymphatic cancer, blood-and lymph-forming bodies





K. 1.1, k., k. 1.2 1.3







Blood deficiency





I. 16.4







Lead





I. 12, l. 2.2







Lead compounds, inorganic





K. 2.5







Bladder cancer





K. 5.2







Hydrogen cyanide





I. 3







Bromine





I. 8. (C).







Bronchitis, chronic





E. 7







Cancers Carcinoma (lung cancer)





K. 4.1







Breast cancer





K. 6.2







Peritoneum (mesothelioma)





K. 2.1







Bursitis (knee, other places than knees)





D. 2, j. 1







Butadiene





K. 1.1. c, k. 1.3







Byssinosis





E. 6







Bending/stretch (knee)





D. 4





 

 







(C):





 





Cadmium (cadmium)





I. 4, K. 4.1. g







Cement industry, casting





In 5







Cervikobrakialt syndrome (chronic neck-shoulder pain)





B. 2







Chloromethyl ether





K. 4.1. (f)







Conjunktivitis allergica





E. 5.2







Coxae (hip bones)





B. 3







Creosote (creosote)





K. 3.1. c







Cyanates Cyanide salts, cyan, connections





I. 3







Cytomegalovirus (infection)





L. 1.1





 

 







(D):





 





Fumes





E. 4, E 5, E. 8







Dementia (toxic/organic brain injury, encephalopathy)





In 3.1, i. 6.1, i. 12.1, i. 13, i. 16.1







Dengue fever





H. 3







Diesel engines





K. 4.1. t, k. 5.2. in







Dimetylformamid





I. 17







Dioxin





1.4. a, k. k. 4.1. a, k., k. 6.1 6.4







DLA professionalis (noise-related hearing impairment)





A. 1







Animals, animal material





H. 1







Animals, animal products





E. 5, e. 8 H 1







Animal protein





E. 6
Deafness, tunghørhed (noise-related hearing impairment)





A. 1





 

 







(E):





 





Eczema, toxic





G.2.







Eczema, allergic





G. 1 in 5.1, i. 9







Extreme physical workload (fetus damage)





L. 3.2







Electrochemical and electro-mechanical industry





I. 6







Encephalopathy (toxic/organic brain damage)





In 3.1, i. 6.1, i. 12.1, i. 13, i. 16.1







Enzymes





E. 5, e. 8







Epicondylitis lateralis (tennis elbow)





C. 4.1







Epicondylitis medialis (golf elbow)





C. 4.2







Epiteliale tumours





K. 4.4







Epoxy resins





E. 5







Erionit





K. 2.1. b, k. 4.2. (b)







Ethylene oxide





K. 1.1. (b)





 

 







(F):





 





' Farmer's lung '





E. 6







Color industry, colours and varnishes





I.4, i.5, i.7, i. 8. A, i. 12, i. 16, 17 in.







Dyes





E 5, E. 8, 17.







Dyes, benzidinbaserede





K. 5.2. f







Fixation of the head (chronic neck-shoulder pain)





B. 2







Flame planing, smoke from





E. 7







Fluoride





I. 15, i. 8. (C)







Fluorosis (bone disease)





I.15







Changes in tendon or senevæv





C. 1







Changes in skulderleddets rotatorsener or biceps tendon





C. 5.1







Formaldehyde





K. 2.6, k. 4.3 (a) k. 1.2. (b)







Phosphorus





I. 11







Phosgene





I. 3







Birth defects





Group L







Framboesi





H. 3







Hairdressing work in men





K. 5.2. l







Fuchsin (magenta manufacturing)





K. 5.2. p







Fireworks





In 14







Physical trauma





L. 4







Birth, premature





L. 3.2, l. 4





 

 







(G):





 





Biliary cancer





K. 2.2







Electroplating





I.3, i.4







Gamma radiation (ionizing radiation)





K. 1.2. a, k. k. 6.2, 6.5







Glass production (art glass, glass containers and pottery)





K. 4.1. island







Glomerulonephritis (kidney damage)





I. 16.2







Golf elbow





C. 4.2







Cataracts





A. 2







Yellow fever





H. 3







Gold and silver work





I. 3







Rubber industry





K. 1.1. d, k. 5.2. n





 

 







(H):





 





Hare sick





L. 1.8







Whole-body vibration (low back pain)





B. 1







Hepatitis





H. 2, l. 1.2







Hepatitis B virus





H. 2, l. 1.2, k. 2.3. (a)







Hepatitis C virus





K. 2.3. b







Toxica hepatitis (liver inflammation)





I. 3.2, i. 16.3, i. 17







Herpes simplex virus (neonatal herpes)





L. 1.3







Hexane





I. 16.5







HIV-infection





L. 1.4 – see also AIDS h. 2







Brain inflammation
L. 1.5, l. 2.2







Brain injury, toxic (dementia, encephalopathy)





In 3.1, i. 6.1, i. 12.1, i. 13, i. 16.1







Hip joints, osteoarthritis in both





B. 3







Skin cancer





K. 3







Skin diseases, allergic





G. 1 in 5.1, i. 9







Skin diseases, other irritative





G.2.







Squatting work/position





D.1, d.3







Human immunodeficiency virus (HIV)





L. 1.4 – see also AIDS h. 2







White finger (morbus Raynaud)





C. 3







Hydrocephalus





L. 1.8







Hydrochloride salts





K. 5.2. (c)







Hearing loss (noise-related)





A. 1







Hematite-mining (mining of iron ore)





K. 4.1. æ







Hand-arm vibration (vibration disease)





C 2 C 3







Hand tools (vibrating)





C. 2 (a), c. 3







Hard metal/hard metals





E. 4, e. 8







Hair loss





In 14





 

 







In:





 





IARC





Group K (see note)







Impingementsyndrom





C. 5.1







Infection





Group H, Group L 1







Infections, infectious diseases





Group H, Group L 1 (see also group K)







Insecticidal (non-containing arsenic are being)





I. 11, K. 4.1. h







Ionizing radiation (such as x-ray and gamma radiation)





K. 1.2. a, k. k. 6.2, 6.5







Isocyanates





E. 5, e., e. 8 9







Insulation vacuum





E. 7







Isopropyl alcohol (manufacture by strong acid process)





K. 4.3. e





 

 







(J):





 





Iron ore (iron shine)





K. 4.1. æ







Iron and metal processes (manufacturing, tempering, molding)





In 3.3, i. 10, k. 4.1. w







Iodine





I. 8. (C)







Jumpers knee (patellar tendinitis)





D. 4





 

 







K:





 





Cadmium (cadmium)





I. 4, K. 4.1. g







Undulant fever





H. 1







Dental caries, sugar and flour-





A. 3.1







Carpal tunnel syndrome





C. 2







Chemical industry, chemical products





I. 1, i. 16, 17 in.







Chemical substances





In Group E, K and l. 2







Chlorine





I. 8. (C)







Klorede solvents





I. 16.3







Aqueous degreasing agents, oxygenation of the





I. 3.3







Chloride (vinyl)





K. 2.3. c, k. 2.4







Chloro-ortho-toluidine and its strong (hydrochloride) salts





K. 5.2. (c)







Bone and joint diseases





C. 3, i. 15







Bone cancer (Sarcoma)





K. 6.3







Knee (osteoarthritis, meniscus bursit, sickness, patellar tendinitis)





Group D







Knæliggende work





D. 1







Cobalt





E. 8 in 10







Cobalt (metallic with tungsten carbide)





E. 8, K. 4.1. l







Coke production





K. 3.1. k, k. 4.1.x







COPD (chronic obstructive pulmonary disease/chronic bronchitis)





E. 7







Compressed air





J.3







Grain and feed





E. 7







Power, powerful, force expansion





Group C
Creosote connections





K. 3.1. c







Chrome





E. 8, i. 5, 5.1







Chromium compounds





K. 4.1. i, K. 4.3. (b)







Chronic bronchitis/COPD





E. 7







Chronic neck-shoulder pain





B. 2







Crystalline quartz (silica)





K. 4.1. (j)







Cancer without specification





K. 6.4







Retinoblastoma





Group K







Hydrocarbons and derivatives





I. 16







Coal gasification





K. 3.1. l, K. 4.1. y, k. 5.2 m







Carbon monoxide





In 3.1







Art glass, glass containers and pottery, production of





K. 4.1. island







Artificial fertilizers, production of





I. 8. (A)







Art resin





E. 5, e. 8







Kunstsilke industry





I. 13







Silica, crystalline (silica)





K. 4.1. (j)







Mercury





I. 6, l. 2.1







Mercury poisoning





I. 6







Nitrogen, nitrogen compounds, nitrogen oxide





I. 8. A, i. 17







Refrigeration plant





I. 8. (A)





 

 







L:





 





Laboratory work





I. 6







Varnishes and colours





I.4, i.5, i.7, i. 8. A, i. 12, i. 16, 17 in.







Larynx-cancer (throat cancer)





K. 4.5







Led





C. 3







Leishmaniasis





H. 3







Lepra





H. 3







Production of pottery, art glass, glass containers and





K. 4.1. island







Leukemia





K. 1.1







Liver inflammation





See hepatitis







Liver cancer





K. 2.2, 2.3, 2.4, k. k.







Liver injury/disease





I.1. , I. 3.2, i. 16.3, i. 17, l., 1.8, 2.2, k. k. k. 2.3 and 2.4







Food industry





I. 17







Listeria





L. 1.5







Air, compressed





J.3







Luftfugtersyge





E. 6







Respiratory tract cancer in





Group k. 4







Lumbago





B. 1







Lumbar herniated disc





B. 1







Pulmonary asbestosis





E. 3.1







Lung inflammation





E. 10







Lung fibrosis





E. 2







Pleural, widespread connective tissue formation





E. 3.2







Pleural cancer (mesothelioma)





K. 4.2







Lung cancer





K. 4.1







Lung disease, after aluminum or hard metals





E. 4, e. 8







Lung disease, after organic material





E. 6







Lung disease with impaired lung function of obstructive type





E. 9







Lung diseases, obstructive





E. 4, E. 7th, e. 8







Lung injury/disease





Group E, E. 7th, e. 8, i. 2, i. 8. A, i. 8. B, i. 8. C, i. 10, i. 11.2, K. 4.1, K. 4.2







Pulmonary edema





I. 11.2







Lymphatic and blood-forming organs





K. 1.3







Lymphoma, Non-Hodgkin





K. 1.4







Running/jumping





D. 4







Boost





B.1, b.3







Lifting of the upper arm, static





C. 5







Lænderygsygdom





B. 1





 

 
M:





 





Magenta production (fuchsin)





K. 5.2. p







Malaria





H. 3







Painter, occupational exposure





K. 4.1. z, k. 5.2. o







Malignant diseases





Group K, l. 3.1







Malta fever





H. 3







Manganese (manganese and manganese induced Parkinsonism)





I.7







Masteoideus, processus (epithelial tumor)





K. 4.4







Stomach, cancer of





K. 2.5







Melk aries





A. 3.1







Pharmaceutical industry





I. 1







Meniscus disease





D. 3







Mental retardation





L. 2.1







Mesothelioma





K. 2.1, K. 4.2







Metal industry





I.1, i.3, i.5







Metallic cobalt particles containing tungsten carbide





K. 4.1. l







Metal lung, hard





I. 10







Metal casting





K. 4.1. v







Methylbiskloranilin (MOCA)





K. 5.2. (d)







Metylbutylketon





I. 16.5







Microcephali





L. l. 1.8, 2.1, l. 3.1







Mining of iron ore with radon exposure





K. 4.1. æ







Mineral oil





K. 3.1. (d)







MOCA (4-4-metylbis chlorine ´ aniline)





K. 5.2. (d)







"Mushroom worker's lung"





E. 6







Myelogenous leukemia





See leukemia







Furniture and Cabinet manufacturing





K. 4.3. (f)







Coins, manufacture of





I. 10





 

 







N:





 





Neck bending





B. 2







Neck-shoulder pain, chronic





B. 2







Neck-shoulder yoke, static load of





B. 2







Naphthylamine





K. 5.2. (a)







Nephrotic syndrome (kidney damage)





I. 6.2







Neonatal injuries/illnesses





Group L







Neonatal varicella





L. 1.9







Nephritis (kidney damage)





I. 6.2, i. 12.3, i. 16.2







Nerve inflammation





In 1.1, i. 12.2, i. 14, 16.5 in.







Nerve paralysis





J. 2







Retinal inflammation





L. 1.8







Neuropathy, polyneuropathy





C. 3, i. 11.1, i. 12.2, i. 14, 16.5 in.







Nickel





I. 9







Nickel compounds including nickel oxides and sulphides and nickel refining industry





K. 4.1. k, k. 4.3. c







Nitroaminer





I. 17







Non-Hodgkin Lymphoma





K. 1.4







Kidney cancer





K. 5.1







Kidney injury





I. 4, i. 6.2, i. 12.3, i. 16.2







Nasal cavity cancer





K. 4.3







Nasal septum perforation,





In 5.4







Nasal pharyngeal cancer





K. 2.6





 

 







O:





 





Oat cell





K. 4.1. (f)







Oil, mineral





K. 3.1. (d)







Oil shale





K. 3.1. (f)







Oil refining





K. 1.1. f, K. 3.1 m







Organic/toxic brain damage





View brain damage (encephalopathy)







Organic nitrogen compounds (nitrogen)





I. 17
Organic materials





E. 6







Organic solvents





I. 16







Psittacosis





H. 1







Ortho-toluidine, 4-chloro-ortho-toluidine





K. 5.2. c, k. 5.2. g





 

 







P:





 





Pappatacifeber





H. 3







Paralysis agitans (manganese induced Parkinsonism, manganism)





I.7







Parasitic diseases





H. 1







Parkinsonism, manganese induced





I.7







Parvovirus B-19





L. 1.6







Passive smoking





K. 4.1 m







Perforation of the nasal partition screens





In 5.4







Peripheral neuropathy





C. 3, i. 11.1, i. 12.2, i. 14, 16.5 in.







Peritendinitis





C. 1







Persulfate salts





E. 5, e. 8







Fever





H. 3







Plants, plant products





E. 5, e. 8







Plastic industry





In 12 of 16







Care work





B. 1







Typhus





H. 3







Pleural plaques (pleural stains)





E. 3.3







Pneumoconiosis (dust lungs)





E. 4







Poliomyelitis





L. 1.6







Polyneuropathy





C. 3, i. 11.1, i. 12.2, i. 14, 16.5 in.







Porcelain and ceramics industry





I. 2







Primary liver cancer (angiosarkom)





K. 2.4







Mental illness





Group F







Post traumatic stress disorder





F. 1





 

 







Q:





 





Q-fever





H. 1





 

 







R:





 





Radio activity





L. 3.1







Radium-226





K. 4.4, k. 6.3







Radium-228





J. 6.3







Radon and "radon daughters"





K. 4.1. n







Radon exposure, mining of iron ore with





K. 4.1. æ







Cleansers





I. 16







Waste disposal installations and wiring





H. 1







Retardation, mental





L. l. 2.1, 2.2







Rhinitis allergica





E. 5.1







Richettsia





H. 3







Rotator cuff syndrome





C. 5.1







Rotatorsener





C. 5.1







Rat poison, manufacture of





In 14







Rubellasyndrom





L. 1.7







Smoking, passive





K. 4.1 m







Rygsygdomme, chronic





B. 1







Shaking Palsy





View manganism







Rubella





L. 1.7







Smoke





E. 7







X-ray radiation (ionizing radiation)





K. 1.2. a, k. k. 6.2, 6.5







Råparaffin





K. 3.1. e





 

 







S:





 





Nitric acid





I. 8. (A)







Sarcoma (bone cancer)





K. 6.3







Tenosynovitis





C. 1







Mustard gas (sulphur mustard)





K. 4.1. o, k. 4.5. (b)







Silica (crystalline silica)
K. 4.1. (j)







Silicon compounds





E. 2







Silicosis





E. 1







Shale oil and lubricants extracted from shale





K. 3.1. (f)







Thyroid cancer





K. 6.5







Shoemaking and repair





K. 1.1. f, K. 4.3. g, k. 5.2. q







Chickenpox virus





L. 1.9







Cirrhosis of the liver





In 1.2







Shoulder joint





C. 5







Skuldertendinit





C. 5.1







Osteoarthritis of the elbow (hand-arm vibrations)





C. 3







Osteoarthritis of the wrist (hand-arm vibrations)





C. 3







Osteoarthritis in both hip joints





B. 3







Osteoarthritis of knee joint





D. 1







Osteoarthritis in low back pain





B. 1







Abrasive





A. 3.2







Inflammation of the mucous membranes, upper respiratory tract, eyes





E. 5.1, 5.2, i. e. 5.3







Mucous membranes in the sinuses and processus masteoideus, cancer of





K. 4.4







Bursa





D. 2, j. 1







Infection diseases





Group H (see also group K and L)







Jewellery, the manufacture of





I. 10







Sod





K. 3.1. h, K. 4.1. p







Solar radiation





K. 3.1. g







Special steel, manufacture of





I. 10







Jumping/running





D. 4







Patellar tendinitis (jumpers knee, tendinitis/tendinosis patellaris)





D. 4.







Explosives industry





I. 8. A, i. 17







Staphylococci





H. 2







Static load of neck-shoulder girdle





B. 2







Coal tar, coal tar pitch





K. 3.1. in, K. 4.1. q, k. 5.2. h







Tetanus





H. 1







Throat cancer (laryngeal cancer)





K. 4.5







Beam energy





A. 2







Radiation





A. 2, k. 1.2. a, k. 3.1. g, k. 6.2, 6.5, k. l. 3.1







Starling, grey





A. 2







Noise, noise-related hearing impairment





A. 1







Dust





E. 4, E 5, E. 7th, e. 8







Boot and shoemaking and repair





K. 1.1. f, K. 4.3. g, k. 5.2. q







Dust lungs (pneumoconiosis), after dust or fumes from aluminium or its compounds or dust from hard metals





E. 4







Steel





In 3 of 10







Sugar and melk aries





A. 3.1







Fungal spores





E. 6







Welding





E. 7







Hydrogen sulfide





I. 13







Sulphur dioxide





I. 8. (B)







Sulfur mustard (mustard gas)





K. 4.1. o, k. 4.5. (b)







Sulphuric acid





I. 8. (B)







Strong inorganic acid mists, sulphuric acid with





K. 4.1. r, k. 4.5. (c)







Visual disturbances





In 14







Acid mists, strong inorganic with sulphuric acid





K. 4.1. r, k. 4.5. (c)







SOAP industry





I. 13





 

 







T:





 





Talc containing asbestos-like fibers





K. 2.1. c, K. 4.1. s, K. 4.2. (c)







Tallium





In 14







Tooth wear (abrasion)





A. 3.2







Tendinit, shoulder





C. 5.2







Tendinitis





C. 1, c. 5, d. 4
Tendinitis patellaris (Jumper's knee, jumpers knee)





D. 4







Tendinosis patellaris (Jumper's knee, jumpers knee)





D. 4







Tendovaginitis





C. 1







Tennis elbow





C. 4.1







Tetrakloretylen





K. 1.4. b







Tetraklorodibenzo-para-dioxin (dioxin)





1.4. a, k. k. 4.1. a, k., k. 6.1 6.4







Fall-back fever





H. 3







Tar (coal)





K. 3., K. 4.1. q







Toxic (irritative) Eczema





G.2.







Toxic brain damage (encephalopathy)





In 3.1, i. 6.1, i. 12.1, i. 13, i. 16.1







Toluener (Alpha-chlorinated)





K. 4.1. b







Toluidine





K. 5.2. c, k. 5.2. g







Toxoplasmosis





L. 1.8







Traumatic events





F. 1







Trauma, physical





L. 4







Trikloretylen





K. 1.4. c, k. 2.2. (b)







Tropical diseases





H. 3







Pressure (compressed air)





J.3







Pressure, exogenous





J. 1, j. (2)







Trypanosomiasis





H. 3







Wood processing





E. 7







Wood treatment products





I. 1







Wood dust





E. 7, K. 4.3. (d)







Tuberculosis





H. 2







Tuberkuløs infection (animals)





H. 1







Tumors, epiteliale





K. 4.4







Tungsten (tungsten carbide), metallic cobalt with





K. 4.1. l







Heavy lifting work, heavy single stroke





B.1, b.3







Teeth and gums





A.3





 

 







U:





 





Exhaust emissions from diesel engines





K. 4.1. t, k. 5.2. in







Forearms





C 1, C 2, C 3







Urinblære cancer





K. 5.2







Urinary tract





Group k. 5







Unspecific dust





E. 7





 

 







(V):





 





Vanadium





E. 10







Varicella zoster virus (chickenpox virus)





L. 1.9







Vibration





B. 1, C 2, C 3







Vibration diseases, hand-arm vibration (havs, peripheral neuropathy, osteoarthritis of the wrist and elbow)





C. 3







Vibration diseases, hand-arm vibration (carpal tunnel syndrome)





C. 2







Vinyl chloride





K. 2.3. c, k. 2.4







Tissue, tissue fluids (infectious diseases of humans)





H. 2





 

 







W:





 





Weil's disease





H. 1







Tungsten carbide, metallic cobalt with





K. 4.1. l





 

 







Island:





 





Eye mucosal inflammation





E. 5.2, 5.3







Upper respiratory mucosal inflammation





I. 5.3







Other bodies, cancers





Group k. 6





 

 







Å:





 





Intellectual impairment, early (dementia)





View toxic brain damage (encephalopathy)